National Oxygen seeks approval for asset sales, new MOA at Aug 28 AGM
National Oxygen Limited turns profitable in FY26 due to asset sales and seeks shareholder approval for further disposals and governance updates at its upcoming AGM.

*this image is generated using AI for illustrative purposes only.
National Oxygen Limited will hold its 51st Annual General Meeting (AGM) on Friday, August 28, 2026, via video conference to seek shareholder approval for the sale of plant and machinery at its SIPCOT Perundurai and Pondicherry units. The meeting also aims to adopt new Memorandum of Association (MOA) and Articles of Association (AOA) aligned with the Companies Act, 2013, and reappoint Managing Director Rajesh Kumar Saraf. These strategic moves follow a ₹183.66 lakh net profit in FY26, driven by an exceptional gain of ₹812.26 lakh from asset sales, reversing a ₹700.22 lakh loss in FY25.
The AGM is scheduled for 11:30 A.M. (IST) and does not require physical presence. Shareholders must hold shares as of the cut-off date, Friday, August 21, 2026, to be eligible for e-voting. The e-voting window opens on Tuesday, August 25, 2026, at 09:00 A.M. and closes on Thursday, August 27, 2026, at 05:00 P.M. To ensure eligibility, the Register of Members and Share Transfer Books will remain closed from Saturday, August 22, 2026, through Friday, August 28, 2026. Central Depository Services Limited (CDSL) serves as the e-voting intermediary, while M/S Lakshmmi Subramanian & Associates acts as the scrutinizer.
Asset Disposal and Governance Updates
The Board seeks special resolutions to sell or dispose of assets at two key locations where production has been permanently discontinued. At the SIPCOT Perundurai unit, production ceased effective May 12, 2025. At the Pondicherry Liquid Production Unit, production stopped effective April 7, 2026. Proceeds from these sales are designated for repaying secured and unsecured bank borrowings and meeting working capital requirements. No purchaser has been identified yet, and the sale consideration remains undetermined.
| Agenda Item | Description | Regulatory Basis |
|---|---|---|
| Asset Sale (SIPCOT) | Disposal of plant, machinery, lease land, and building | Section 180(1)(a), Companies Act, 2013; Reg 37A, SEBI LODR |
| Asset Sale (Pondicherry) | Disposal of plant and machinery in Liquid Unit | Section 180(1)(a), Companies Act, 2013; Reg 37A, SEBI LODR |
| MOA Adoption | Replace existing MOA with new version per Companies Act, 2013 | Section 4 & 13, Companies Act, 2013 |
| AOA Adoption | Replace existing AOA with new version per Table F, Schedule I | Section 14, Companies Act, 2013 |
Additionally, Rajesh Kumar Saraf, Managing Director, retires by rotation and offers himself for re-appointment. He holds 17,66,037 shares and drew remuneration of ₹54,00,000 in FY26. The Board noted the demise of Gajanand Saraf, Whole-Time Director, who passed away on April 6, 2026. Statutory auditor PSDY & Associates issued an unqualified report on the financial statements.
What the Numbers Show
The transition to profitability in FY26 is structural rather than operational, entirely dependent on the one-time exceptional gain of ₹812.26 lakh from asset sales. Excluding this benefit, the company would have recorded a pre-tax loss, highlighting that core business profitability remains under pressure from reduced capacity. While the reduction in interest expenses indicates improved debt management, the reliance on asset monetization underscores the urgency for sustainable operational improvements in the remaining units to support long-term viability.
Historical Stock Returns for National Oxygen
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.56% | -1.84% | +8.30% | -17.76% | -52.41% | -21.73% |
How will the proceeds from the SIPCOT and Pondicherry asset sales specifically impact National Oxygen's debt-to-equity ratio and interest coverage in the upcoming fiscal year?
What is the management's strategic roadmap for revitalizing core operational profitability at the remaining active units after the one-time asset gains are excluded?
How might the reappointment of MD Rajesh Kumar Saraf and the recent loss of Whole-Time Director Gajanand Saraf influence the company's governance stability and executive decision-making?


































